A recent Politico article noted that Pfizer and its partner BioNTech are seeking full approval from the FDA for their Covid-19 vaccine for people 16 and older. The two-dose protection against coronavirus received emergency use authorization earlier this year, which allowed it to be one of three vaccines used in the pandemic battle. Full approval means the companies would be able to market the shot directly to consumers, and make it easier for schools, employers, and the military to require vaccination against Covid-19.
Pfizer Eyes Full FDA Approval for Covid-19 Vaccine
Pfizer and partner BioNTech are the first vaccine manufacturers to seek full approval in the U.S.
May 10, 2021
Recommended
Recommended
Sustainable Healthcare Packaging Solutions That Work
Industry leaders share proven strategies for reducing packaging emissions by up to 70% while meeting safety and regulatory requirements.
Read More
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Downloads
